Risk of allergic reaction in patients with atopic disease and recent coronavirus disease 2019 vaccination

Ann Allergy Asthma Immunol. 2021 Aug;127(2):257-258. doi: 10.1016/j.anai.2021.04.024. Epub 2021 May 5.

Authors

Kelley N Dages¹, Mitchell M Pitlick², Avni Y Joshi², Miguel A Park³

Affiliations

¹ Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
² Division of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota.
³ Division of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: park.miguel@mayo.edu.

No abstract available

MeSH terms

2019-nCoV Vaccine mRNA-1273
Adult
Aged
Aged, 80 and over
Anaphylaxis / epidemiology*
Anaphylaxis / immunology
BNT162 Vaccine
COVID-19 / immunology
COVID-19 / prevention & control*
COVID-19 Vaccines / adverse effects*
COVID-19 Vaccines / immunology
Female
Humans
Immunotherapy / adverse effects
Infusions, Subcutaneous
Male
Middle Aged
Retrospective Studies
SARS-CoV-2 / immunology
Young Adult

Substances

COVID-19 Vaccines
2019-nCoV Vaccine mRNA-1273
BNT162 Vaccine